About Tm Bioscience
Tm Bioscience is a Healthcare company based in Toronto (Canada) founded in 1992, and was acquired by Luminex in December 2006. DNA-based tests for genetic disorders, drug metabolism and infectious diseases. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics.
Company details
Tm Bioscience is focussed on developing DNA-based tests for genetic disorders, drug metabolism (pharmacogenetics) and infectious diseases. It has developed Analyte Specific Reagents and a series of Tag-It tests for a variety of genetic disorders based on its proprietary Tag-It Universal Array platform. It also provides Respiratory Viral Panel (RVP) which it claims as a reliable and cost- effective test designed to play a key role in patient management, infection control and in countering the pandemic threat of respiratory diseases. Its Cystic Fibrosis (CF) test is the multiplexed human disease genotyping test to be cleared by the FDA for diagnostic use in the US. Besides, it was also developing a companion test for the blood-thinning drug warfarin and a test for patients under treatment for sepsis. In March 2013 Luminex acquired Tm Bioscience for an undisclosed amount.
- Headquarters Toronto, Canada
- Stage Acquired
- SectorsHealthcare
- Website tmbioscience.com
- Social LinkedIn
- Acquired by Luminex (Dec 2006)
- Investors
- Acquired byLuminex
(Dec 2006)
Investors in Tm Bioscience
Tm Bioscience has secured backing from 1 investor. Prominent investors backing the company include Luminex Corporation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of instruments, reagents and kits for clinical diagnostics and life science research | 1995 | luminexcorp.com | Austin, United States |
Investor details for Tm Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Tm Bioscience
2 dated milestones of Tm Bioscience across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Tm Bioscience is founded.
- Exit Acquired by Luminex.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Tm Bioscience
Tm Bioscience was founded in 1992.
Tm Bioscience is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Tm Bioscience is focussed on developing DNA-based tests for genetic disorders, drug metabolism (pharmacogenetics) and infectious diseases. It has developed Analyte Specific Reagents and a series of Tag-It tests for a variety of genetic disorders based on its proprietary Tag-It Universal Array platform. It also provides Respiratory Viral Panel (RVP) which it claims as a reliable and cost- effective test designed to play a key role in patient management, infection control and in countering the pandemic threat of respiratory diseases. Its Cystic Fibrosis (CF) test is the multiplexed human disease genotyping test to be cleared by the FDA for diagnostic use in the US. Besides, it was also developing a companion test for the blood-thinning drug warfarin and a test for patients under treatment for sepsis. In March 2013 Luminex acquired Tm Bioscience for an undisclosed amount.
Tm Bioscience has 1 investor. Key investors include Luminex Corporation.
Yes. Tm Bioscience was acquired by Luminex in December 2006.